Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P1200: Study of correlation between polymorphisms of vitamin D metabolism genes and perianal disease in Crohn@E@s diseaseECCO'24
Year: 2024
Authors: Ribaldone, D.G.(1)*;Cafasso, C.(2);Antonucci, M.(2);Palermiti, A.(2);Caviglia, G.P.(2);Vernero, M.(2);D@E@Avolio, A.(2);Cusato, J.(2);
(1)University of Turin, Department of Mediical Sciences, Turin, Italy;(2)University of Turin, Department of Medical Sciences, Turin, Italy;
P1201: Association between Inflammatory Bowel Disease and Henoch-Schönlein purpura: A Bidirectional Two-Sample Mendelian Randomization StudyECCO'24
Year: 2024
Authors: Yu , Q.(1);Luo , J.(1)*;Zhang , Y.(2);Chen , J.(3);Wang , X.(1);Lu , X.(4);lv , M.(1);Li , S.(1);Huang , X.(5);Hu , W.(6);Zhang , M.(1);Liu , L.(1);Hu , Y.(1);Xu , J.(1);Xu , D.(1);Zhang , H.(1);Chen , M.(1);Roozbahani , A.(7);Ghoushi , E.(7);Chen , Y.(1);
(1)the Second Affiliated Hospital Zhejiang University School of Medicine, IBD centre- Department of gastroenterology, Hangzhou, China;(2)the Second Affiliated Hospital Zhejiang University School of Medicine, Department of cardiology, Hangzhou, China;(3)Zhejiang University School of Medicine, Centre for Global Health, Hangzhou, China;(4)Zhejiang University School of Medicine, IBD centre- Department of rheumatology, Hangzhou, China;(5)the Second Affiliated Hospital Zhejiang University School of Medicine, IBD centre- Department of nutrition, Hangzhou, China;(6)The First Affiliated Hospital- Zhejiang University School of Medicine, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China;(7)School of Medicine- Zhejiang University, School of Medicine- Zhejiang University, Hangzhou, China;
P1202: Genome wide association study result for inflammatory bowel disease: A single institute experience in TaiwanECCO'24
Year: 2024
Authors: Huang, P.J.(1)*;Sun, T.H.(2);Hsu, K.C.(2);Wang, C.P.(3);Wu, Y.H.(4);Chou, J.W.(4);Cheng, K.S.(4);
(1)China Medical University Hospital, Department of Gastroenterology, Taichung City, Taiwan;(2)China Medical University Hospital- Taichung- Taiwan, Artificial Intelligence Center- China Medical University Hospital- Taichung- Taiwan, Taichung, Taiwan;(3)China Medical University Hospital- Taichung- Taiwan, Center for Digestive Medicine- Department of Internal Medicine- China Medical University Hospital- China Medical University Hospital- Taichung- Taiwan, Taichung, Taiwan;(4)China Medical University Hospital- China Medical University Hospital- Taichung- Taiwan, Center for Digestive Medicine- Department of Internal Medicine- China Medical University Hospital- China Medical University Hospital- Taichung- Taiwan, Taichung, Taiwan;
P1203: Fecal transplantation for Ulcerative Colitis from diet conditioned donors followed by dietary intervention results in favorable gut microbial profile and decreased gut inflammation compared to fecal transplantation aloneECCO'24
Year: 2024
Authors: Leibovitzh, H.(1)*;Sarbagili Shabat, C.(2);Hirsch, A.(1);Zittan, E.(3);Mentella, M.C.(4);Petito, V.(5);Cohen, N.A.(1);Ron, Y.(1);Fliss Isakov, N.(1);Pfeffer, J.(6);Yaakov, M.(7);Fanali, C.(5);Turchini, L.(5);Masucci, L.(8);Quaranta, G.(8);Kolonimos, N.(3);Godneva, A.(9);Weinberger, A.(9);Scaldaferri, F.(10);Maharshak, N.(1);
(1)Tel Aviv University- Faculty of Medicine, Tel Aviv Sourasky Medical Center- IBD Center- Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(2)Wolfson Medical Center- Holon- Israel, Pediatric Gastroenterology Unit- PIBD Research Center-, Holon, Israel;(3)Haemek Medical Center- Afula- Israel, Gastroenterology Institute- IBD Unit, Afula, Israel;(4)Università Cattolica del Sacro Cuore- Rome- Italy, UOC di Nutrizione Clinica- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;(5)Fondazione Policlinico ‘A. Gemelli’ IRCCS- Rome- Italy, Cemad [CENTER for Digestive Disease]- UOC Medicina Internae Gastroenterologia, Rome, Italy;(6)Tel Aviv Sourasky Medical Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(7)Wolfson Medical Center- Holon- Israel, Pediatric Gastroenterology Unit- PIBD Research Center, Holon, Israel;(8)Istituto di Microbiologia- Università Cattolica del Sacro Cuore – Fondazione Policlinico ‘A. Gemelli’ IRCSS- Rome- Italy, Dipartimento Scienze di Laboratorio e Infettivologiche- Fondazione Policlinico Universitario A. Gemelli IRCCS- Rome- Italy, Rome, Italy;(9)Weizmann Institute of Science- Rehovot- Israel, Department of Computer Science and Applied Mathematics, Rehovot, Israel;(10)Cemad [CENTER for Digestive Disease]- UOC Medicina Internae Gastroenterologia- Fondazione Policlinico ‘A. Gemelli’ IRCCS- Rome- Italy, Dipartimento di Medicina e Chirurgia Traslazionale- Università Cattolica del Sacro Cuore- Fondazione Policlinico ‘A. Gemelli’ IRCCS- Rome- Italy, Rome, Italy;
P1204: Oral Streptococcus mutans isolates aggravated colitis in miceECCO'24
Year: 2024
Authors: Chen, J.(1)*;Yang, C.(1);Xu, Y.(1);Zhao, Y.(1);Wu, J.(1);Liu, Y.(1);Chen, N.(1);
(1)Peking University People@E@s Hospital, Department of Gastroenterology, Beijing, China;
P1205: Features of the gut microbiota that associate with clinical outcomes of fecal microbiota transplantation in Ulcerative Colitis: a systematic review and meta-analysisECCO'24
Year: 2024
Authors: Benard, M.(1)*;de Goffau, M.(2);Blonk, J.(3);Hugenholtz, F.(4);van Buuren, J.(5);Paramsothy, S.(6);Kaakoush, N.(7);Borody, T.(8);Kamm, M.(9);Ponsioen, C.(3);
(1)Amsterdam University Medical Centers- University of Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism AGEM- Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam University Medical Centers- University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands;(3)Amsterdam University Medical Centers- University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(4)Amsterdam University Medical Centers- University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, The Netherlands;(5)Amsterdam University Medical Centers, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)The University of Sydney, Faculty of Medicine and Health, Sydney, Australia;(7)University of New South Wales, School of Biomedical Sciences, Sydney, Australia;(8)Centre for Digestive Diseases CDD, Department of Gastroenterology, Five Dock, Australia;(9)St Vincent@E@s Hospital, Department of Gastroenterology, Melbourne, Australia;
P1206: Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn’s disease- multi-omic analysis of a prospective cohortECCO'24
Year: 2024
Authors: Godny, L.(1,2)*;Elial-Fatal, S.(1);Arrouasse, J.(1,3);Sharar Fischler , T.(1,4);Reshef, L.(5);Kutokov, Y.(1);Cohen, S.(1);Pfeffer-Gik , T.(1,2);Barkan, R.(1);Shakhman, S.(1,2);Friedenberg, A.(1);Pauker, M.H.(1);Rabinowitz, K.(1,3);Shaham Barda, E.(1,3);Eran-Banai , H.(1,4);Ollech, J.(1,4);Snir, Y.(1,4);Broitman, Y.(1,4);Avni-Biron , I.(1,4);Gophna, U.(5);Yanai , H.(1,4);Dotan, I.(1,4);
(1)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(2)Rabin Medical Center, Nutrition Unit, Petah Tikva, Israel;(3)Tel Aviv University, Felsenstein Medical Research Center- Faculty of Medicine, Tel Aviv, Israel;(4)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;(5)Tel Aviv University, The Shmunis School of Biomedicine and Cancer Research, Tel Aviv, Israel;
P1207: Microbiome composition determines sustained remission after the Crohn’s Disease Exclusion Diet (CDED) with or without Partial Enteral Nutrition in adults with mild-moderate Crohn’s disease; Results from the CDED-AD Pilot Randomized Controlled TrialECCO'24
Year: 2024
Authors: Sigall-Boneh, R.(1,2)*;Organ, S.(3);Yanai, H.(4,5); Maharshak, N.(6);Dotan, I.(7,8);Abramas, L.(9);Wine, E.(10); Widesma, N.(11);Gu, H.(12,13); Bielawski, J.(3,14,15);Dunn, K.(12,15); Van Limbergen, J.(16,17);
(1)Edith Wolfson Medical Center, PIBD Research Center- Pediatric Gastroenterology and Nutrition Unit, Holon, Israel;(2)Tytgat Institute for Liver and Intestinal Research-University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands;(3)Dalhousie University, Department of Mathematics and Statistics, Halifax, Canada;(4)Rabin Medical Center, IBD center- Division of Gastroenterology-, Petah Tikva, Israel;(5)Tel Aviv University-, Faculty of Medicine- Tel Aviv- Israel, Tel Aviv, Israel;(6)Tel Aviv Sourasky Medical Center, Department of Gastroenterology and Hepatology, Tel Aviv, Israel;(7)Rabin Medical Center, IBD center- Division of Gastroenterology, Petah Tikva, Israel;(8)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;(9)The E. Wolfson Medical Center, Pediatric Gastroenterology and Nutrition Unit-, Holon, Israel;(10)University of Alberta, Division of Pediatric Gastroenterology- Department of Pediatrics, Edmonton AB, Canada;(11)Amsterdam University Medical Centers, Division of Nutrition and Dietetics, Amsterdam, The Netherlands;(12)Dalhousie University, Department of Biochemistry and Molecular Biology, Halifax, Canada;(13)Dalhousie University, Department of Mathematics and Statistics-, Halifax, Canada;(14)Dalhousie University, Department of Biochemistry and Molecular Biology, - Halifax-, Canada;(15)Dalhousie University, Institute for Comparative Genomics, Halifax, Canada;(16)Tytgat Institute for Liver and Intestinal Research- University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands;(17)Amsterdam University Medical Centers- Emma Children’s Hospital-, Department of Paediatric Gastroenterology and Nutrition, Amsterdam, The Netherlands;
P1208: MH002, an optimized live biotherapeutic product, for the treatment of inflammatory bowel diseases, has mode-of-actions linked to restoration of intestinal dysbiosis, mucosal integrity, and immune homeostasisECCO'24
Year: 2024
Authors: Bolca, S.(1)*;Pinheiro, I.(1);Gottardi, D.(1);Van den Bossche, L.(1);Haazen, L.(1);Possemiers, S.(1);
(1)MRM Health NV, Research & Development, Zwijnaarde, Belgium;
P1209: Baseline gut microbiota composition and function reflect response to 5-ASA treatment in Ulcerative Colitis.ECCO'24
Year: 2024
Authors: Radhakrishnan, S.T.(1)*;Alexander, J.L.(1);Mullish, B.H.(1);Danckert, N.P.(2);Valdivia-Garcia, M.A.(1);Serrano-Contreras, J.I.(1);Balarajah, S.(1);Perry, R.(1);Gallagher, K.I.(1);Hicks, L.C.(1);Powell, N.(1);Li, J.V.(1);Marchesi, J.R.(1);Williams, H.R.T.(1);
(1)Imperial College London, Metabolism- Digestion and Reproduction, London, United Kingdom;(2)Kings College London, Life Sciences & Medicine, London, United Kingdom;
P120: A novel population of classical monocytes is expanded in CD and defined by an upregulation of genes relating to mononuclear cell differentiation and response to microbes.ECCO'24
Year: 2024
Authors: Gadhok, R.(1)*;Hornsby, E.(1);Kok, K.B.(2);Lindsay, J.O.(1);Stagg, A.J.(1);
(1)Blizard Institute- Queen Mary University of London, Centre for Immunobiology, London, United Kingdom;(2)The Royal London Hospital, Department of Gastroenterology, London, United Kingdom;
P1210: Gut microbiota profiling and disease course in patients with ulcerative colitis in clinical remissionECCO'24
Year: 2024
Authors: SinghD.M., A.(1);Sundharam S, S.(2)*;Midha, V.(3);Singh, D.(4);Mahajan, R.(5);Krishnamurthi, S.(2);Sood, A.(5);
(1)Dayanand Medical College and Hospital- Ludhiana, Department of Gastroenterology, Ludhiana, India;(2)CSIR-Institute of Microbial Technology, Microbial Type Culture Collection & Gene Bank MTCC, Chandigarh, India;(3)Dayanand Medical College and Hospital, Medicine, Ludhiana, India;(4)Dayanand Medical College and Hospital, Research and Development, Ludhiana, India;(5)Dayanand Medical College and Hospital, Gastroenterology, Ludhiana, India;
P1211: A faecal microbial signature, in combination with faecal calprotectin, to optimise endoscopic activity monitoring in Crohn’s DiseaseECCO'24
Year: 2024
Authors: Taboada-López, S.(1)*;Malagón, M.(1);Amoedo, J.(1);Ramió-Pujol, S.(1);Busquets, D.(2);Bahi, A.(3);Gilabert, P.(4);Rodríguez-Alonso, L.(4);Mañosa, M.(5);Cañete, F.(5);Torres, P.F.(5);Morales, V.J.(6);Delgado-Guillena, P.G.(6);Domenech, E.(5);Guardiola, J.(4);Serra-Pagès, M.(1);Garcia-Gil, L.J.(7);Aldeguer, X.(2);
(1)GoodGut SLU, R+D department, Girona, Spain;(2)Hospital Universitari de Girona Dr. Josep Trueta, Gastroenterology department, Girona, Spain;(3)Institut d’Investigació Biomèdica de Girona-IDIBGI, Digestive & Endocrinology Department, Girona, Spain;(4)Hospital Universitari de Bellvitge, Digestive Diseases Department, Barcelona, Spain;(5)Hospital Universitari Germans Trias i Pujol, Gastroenterology department, Badalona, Spain;(6)Hospital General de Granollers, Gastroenterology department, Granollers, Spain;(7)Universitat de Girona, Biology Department, Girona, Spain;
P1212: Effects of Enterococcus faecalis-derived Gelatinase E on HCT16 colorectal cancer cellsECCO'24
Year: 2024
Authors: Henstra, C.(1)*;Fadavizad, K.(1);Van Praagh, J.(2);Olinga, P.(1);Nagelkerke, A.(3);
(1)University of Groningen, Pharmaceutical Technology & Biopharmacy, Groningen, The Netherlands;(2)University of Groningen, Department of Surgery, Groningen, The Netherlands;(3)University of Groningen, Pharmaceutical Analysis, Groningen, The Netherlands;
P1213: The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patientsECCO'24
Year: 2024
Authors: Puca, P.(1)*;Del Chierico, F.(2);Graziani, C.(3);Masi, L.(4);Coppola, G.(3);Di Vincenz, F.(4);Capobianco, I.(4);Lopetuso, L.R.(3);Barbaro, M.R.(5);Masucci, L.(6);Putignani, L.(7);Petito, V.(3);Marasco, G.(5);Sanguinetti, M.(8);Barbara, G.(5);Gasbarrini, A.(4);Scaldaferri, F.(3);
(1)POLICLINICO AGOSTINO GEMELLI, IBD Unit- CEMAD- Fondazione Policlinico Universitario Agostino Gemelli IRCCS- Rome- Italy., ROMA, Italy;(2)Bambino Gesù Children@E@s Hospital- IRCCS, Immunology- Rheumatology and Infectious Diseases Research Area- Unit of Human Microbiome-, Rome, Italy;(3)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IBD Unit- CEMAD, Rome, Italy;(4)Università Cattolica del Sacro Cuore- sede di Roma, Dipartimento di medicina traslazionale, Rome, Italy;(5)University of Bologna, Department of Medical and Surgical Sciences, Bologna, Italy;(6)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Microbiology Unit-, Rome, Italy;(7)Bambino Gesù Children@E@s Hospital- IRCCS, Unit of Microbiology and Diagnostic Immunology- Unit of Microbiomics and Immunology- Rheumatology and Infectious Diseases Research Area- Unit of Human Microbiome, Rome, Italy;(8)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Microbiology Unit, Rome, Italy;
P1214: The crosstalk between oral and intestinal microbiota in inflammatory bowel disease patientsECCO'24
Year: 2024
Authors: Xiang, B.(1)*;Runzhi, C.(2);Min, Z.(1);Yuanqi, Z.(1);Xiang, P.(1);Wei, W.(1);Qi, Z.(1);Zhiyin, G.(1);Jun, H.(3);Tao, D.(2);Min, Z.(1);
(1)The Sixth Affiliated Hospital of Sun Yat-sen University, Gastroenterology, Guangzhou, China;(2)Zhongshan School of Medicine of Sun Yat-sen University, Immunology and Microbiology, Guangzhou, China;(3)The Sixth Affiliated Hospital of Sun Yat-sen University, Guangdong Institute of Gastroenterology, Guangzhou, China;
P1215: Blastocystis is very rare in faeces of children with Crohn’s disease: quantity, subtyping and association with the faecal bacteriomeECCO'24
Year: 2024
Authors: Hurych, J.(1)*;Hlináková, L.(2);Lerchová, T.(3);Kubát, M.(3);Malcová, H.(4);Cebecauerová, D.(4);Hradský, O.(3);Bronský , J.(3);Cinek, O.(2);
(1)Charles University- Second Faculty of Medicine & Motol University Hospital, Department of Medical Microbiology, Praha, Czech Republic;(2)Charles University- Second Faculty of Medicine & Motol University Hospital, Department of Medical Microbiology, Prague, Czech Republic;(3)Charles University- Second Faculty of Medicine & Motol University Hospital, Department of Paediatrics, Prague, Czech Republic;(4)Motol University Hospital, Department of Pediatric and Adult Rheumatology, Prague, Czech Republic;
P1216: Oral Health status in Inflammatory Bowel Disease patientsECCO'24
Year: 2024
Authors: Rodrigues, C.(1)*;Gomes, A.(2);Mendes, K.(2);Correia, M.J.(2);Rosa, N.(2);Pereira, P.(2);C. Lopes, P.(2);Martins, R.(2);Veiga, N.(2);Soares, C.(1);Ministro, P.(3);
(1)Centro Hospitalar Tondela-Viseu, Gastroenterology Department, Viseu, Portugal;(2)Universidade Católica Portuguesa- Faculty of Dental Medicine, Center for Interdisciplinary Research in Health, Viseu, Portugal;(3)Centro Hospitalar Tondela-Viseu, Gastroenterology Department-, Viseu, Portugal;
P1217: The gut microbiota as a determinant in the development of post-surgical recurrence in Crohn`s disease.ECCO'24
Year: 2024
Authors: Ortiz Sánchez , A.(1);Martinez Tirado , M.P.(1);Rodriguez Nogales , A.(2);Moron Romero , R.(3);Rodriguez Cabezas , M.E.(4);Martin Rodriguez, M.D.M.(5)*;
(1)Clinic San Cecilio Hospital, Gastroenterology, Granada, Spain;(2)Granada University, Farmacology, Granada, Spain;(3)Clinic San Cecilio Hospital, Farmacology, Granada, Spain;(4)Instituto de Investigación Biosanitaria de Granada, Farmacology, Granada, Spain;(5)Hospital Virgen de las Nieves, Granada, Spain;
P1218: Non-invasive point-of-care stool sample for detection of Cytomegalovirus infection in patients with Active or Refractory Ulcerative Colitis using multiplex polymerase chain reaction (mPCR): a pilot feasibility study.ECCO'24
Year: 2024
Authors: Peneva, P.(1)*;Lyutakov, I.(1);Valkov, H.(1);Vladimirov, B.(1);Penchev, P.(1);
(1)Clinic of Gastroenterology- University Hospital @D@Tsaritsa Yoanna-ISUL@D@, Department of Gastroenterology- Medical University - Sofia- Bulgaria, Sofia, Bulgaria;